Portal de investigación
Rapid regression of exudative maculopathy in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome after intravitreal ranibizumab.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Navarrete J
Grupos
Abstract
The idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome is a rare retinal vascular disorder characterized by multiple leaking aneurysmal dilations, retinal vasculitis, neuroretinitis and peripheral vascular ischemia. Visual loss mainly occurs due to the development of retinal neovascularization and/or exudative maculopathy. Although the treatment of choice has not yet been established, retinal photocoagulation seems to be the best option to control the disease and to prevent its progression. Herein, we report a case of idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome with both retinal neovascularization and macular exudation successfully managed with intravitreal ranibizumab (Lucentis(®)) as adjunctive therapy to retinal photocoagulation.
Filiaciones
Keywords
- Exudative maculopathy, Idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome, Ranibizumab
Cita
MARÍN C,GALLEGO R,SALOM D,Navarrete J,DÍAZ M. Rapid regression of exudative maculopathy in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome after intravitreal ranibizumab. Case Rep. in Ophthalmology. 2012. 3. (2):p. 251-257.